Abiopharma

🔍 Zitting Shaun Ellen (Executive)

Company: NIQ Global Intelligence plc (NIQ)

Report Date: 2026-08-20

Detailed Transactions and Holdings:

• Sold 2,802 shares of Ordinary Shares at $18.31 per share (Direct)
  Date: 2026-08-20 | Code: F | equity_swap_involved: 0 | shares_owned_after: 129,550.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Ordinary Shares (Direct)
  Date: 2026-08-20 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 228,229.00 | Footnotes: F2

Footnotes:

• F1: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of RSUs that vested on August 20, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.
• F2: Represents shares held by AI PAVE (Luxembourg) Management & Cy S.C.Sp. for the benefit of the reporting person subject to vesting under the applicable award agreement.